Sevelamer Hydrochloride Tablet, Film Coated
Product Images NDC 72162-2500

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Hydrochloride (NDC 72162-2500). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622500)

The text provides information about Sevelamer Hydrochloride tablets containing 400 mg each. It includes details on dosage and administration, storage instructions, and manufacturer information. The tablets should be dispensed in a tight container to protect from moisture and stored at 20°C to 25°C. Additional details such as NDC number, package size, and prescribing information are also mentioned.*

FDA Label Image

Figure-2 (Sevelamer Figure 2)

This text appears to be a table showing the percentage of patients with reductions in serum phosphorus levels after treatment with Sevelamer Hydrochloride compared to an active control. The table suggests that there was improvement in reducing serum phosphorus levels from baseline with Sevelamer Hydrochloride. It also indicates the reduction in serum phosphorus in mg/dL.*

FDA Label Image

Figure-3 (Sevelamer Figure 3)

FDA Label Image

Figure-1 (Sevelamer Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.